[ad_1]
Tech earnings still won’t answer the question of whether AI spending is paying off beyond Nvidia and a few chip and hardware makers.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...